189 related articles for article (PubMed ID: 9204210)
1. Model SV40-transformed fibroblast lines for metabolic studies of human prosaposin and acid ceramidase deficiencies.
Chatelut M; Harzer K; Christomanou H; Feunteun J; Pieraggi MT; Paton BC; Kishimoto Y; O'Brien JS; Basile JP; Thiers JC; Salvayre R; Levade T
Clin Chim Acta; 1997 Jun; 262(1-2):61-76. PubMed ID: 9204210
[TBL] [Abstract][Full Text] [Related]
2. Saposins (sap) A and C activate the degradation of galactosylceramide in living cells.
Harzer K; Paton BC; Christomanou H; Chatelut M; Levade T; Hiraiwa M; O'Brien JS
FEBS Lett; 1997 Nov; 417(3):270-4. PubMed ID: 9409731
[TBL] [Abstract][Full Text] [Related]
3. Sulfatide and sphingomyelin loading of living cells as tools for the study of ceramide turnover by lysosomal ceramidase--implications for the diagnosis of Farber disease.
Levade T; Tempesta MC; Moser HW; Fensom AH; Harzer K; Moser AB; Salvayre R
Biochem Mol Med; 1995 Apr; 54(2):117-25. PubMed ID: 8581356
[TBL] [Abstract][Full Text] [Related]
4. Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease.
Bradová V; Smíd F; Ulrich-Bott B; Roggendorf W; Paton BC; Harzer K
Hum Genet; 1993 Sep; 92(2):143-52. PubMed ID: 8370580
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of acid ceramidase activity by saposin D.
Azuma N; O'Brien JS; Moser HW; Kishimoto Y
Arch Biochem Biophys; 1994 Jun; 311(2):354-7. PubMed ID: 8203897
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of GM1 ganglioside in cultured skin fibroblasts: anomalies in gangliosidoses, sialidoses, and sphingolipid activator protein (SAP, saposin) 1 and prosaposin deficient disorders.
Schmid B; Paton BC; Sandhoff K; Harzer K
Hum Genet; 1992 Jul; 89(5):513-8. PubMed ID: 1634229
[TBL] [Abstract][Full Text] [Related]
7. Ceramide accumulation is associated with increased apoptotic cell death in cultured fibroblasts of sphingolipid activator protein-deficient mouse but not in fibroblasts of patients with Farber disease.
Tohyama J; Oya Y; Ezoe T; Vanier MT; Nakayasu H; Fujita N; Suzuki K
J Inherit Metab Dis; 1999 Jun; 22(5):649-62. PubMed ID: 10399097
[TBL] [Abstract][Full Text] [Related]
8. Neurodegenerative course in ceramidase deficiency (Farber disease) correlates with the residual lysosomal ceramide turnover in cultured living patient cells.
Levade T; Moser HW; Fensom AH; Harzer K; Moser AB; Salvayre R
J Neurol Sci; 1995 Dec; 134(1-2):108-14. PubMed ID: 8747852
[TBL] [Abstract][Full Text] [Related]
9. A simple method for screening for Farber disease on cultured skin fibroblasts.
Chatelut M; Feunteun J; Harzer K; Fensom AH; Basile JP; Salvayre R; Levade T
Clin Chim Acta; 1996 Feb; 245(1):61-71. PubMed ID: 8646815
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of acid ceramidase deficiency in patients with Farber disease.
Bär J; Linke T; Ferlinz K; Neumann U; Schuchman EH; Sandhoff K
Hum Mutat; 2001 Mar; 17(3):199-209. PubMed ID: 11241842
[TBL] [Abstract][Full Text] [Related]
11. Further evidence that human lysosomal sialidase is not derived from prosaposin. Prosaposin biosynthesis and ganglioside sialidase studies in prosaposin- and sialidase-deficient fibroblast lines.
Paton BC; Schneider-Jakob HR; Kopitz J; Harzer K; Poulos A; Cantz M
Biol Chem Hoppe Seyler; 1994 Jan; 375(1):25-9. PubMed ID: 8003252
[TBL] [Abstract][Full Text] [Related]
12. Natural ceramide is unable to escape the lysosome, in contrast to a fluorescent analogue.
Chatelut M; Leruth M; Harzer K; Dagan A; Marchesini S; Gatt S; Salvayre R; Courtoy P; Levade T
FEBS Lett; 1998 Apr; 426(1):102-6. PubMed ID: 9598987
[TBL] [Abstract][Full Text] [Related]
13. Saposins (sap) A and C activate the degradation of galactosylsphingosine.
Harzer K; Hiraiwa M; Paton BC
FEBS Lett; 2001 Nov; 508(1):107-10. PubMed ID: 11707278
[TBL] [Abstract][Full Text] [Related]
14. A fluorescence-based high-performance liquid chromatographic assay to determine acid ceramidase activity.
He X; Li CM; Park JH; Dagan A; Gatt S; Schuchman EH
Anal Biochem; 1999 Oct; 274(2):264-9. PubMed ID: 10527524
[TBL] [Abstract][Full Text] [Related]
15. Combined saposin C and D deficiencies in mice lead to a neuronopathic phenotype, glucosylceramide and alpha-hydroxy ceramide accumulation, and altered prosaposin trafficking.
Sun Y; Witte DP; Zamzow M; Ran H; Quinn B; Matsuda J; Grabowski GA
Hum Mol Genet; 2007 Apr; 16(8):957-71. PubMed ID: 17353235
[TBL] [Abstract][Full Text] [Related]
16. Turnover of endogenous ceramide in cultured normal and Farber fibroblasts.
van Echten-Deckert G; Klein A; Linke T; Heinemann T; Weisgerber J; Sandhoff K
J Lipid Res; 1997 Dec; 38(12):2569-79. PubMed ID: 9458280
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor.
Burkhardt JK; Hüttler S; Klein A; Möbius W; Habermann A; Griffiths G; Sandhoff K
Eur J Cell Biol; 1997 May; 73(1):10-8. PubMed ID: 9174667
[TBL] [Abstract][Full Text] [Related]
18. In situ assay of acid sphingomyelinase and ceramidase based on LDL-mediated lysosomal targeting of ceramide-labeled sphingomyelin.
Levade T; Leruth M; Graber D; Moisand A; Vermeersch S; Salvayre R; Courtoy PJ
J Lipid Res; 1996 Dec; 37(12):2525-38. PubMed ID: 9017505
[TBL] [Abstract][Full Text] [Related]
19. Insertional mutagenesis of the mouse acid ceramidase gene leads to early embryonic lethality in homozygotes and progressive lipid storage disease in heterozygotes.
Li CM; Park JH; Simonaro CM; He X; Gordon RE; Friedman AH; Ehleiter D; Paris F; Manova K; Hepbildikler S; Fuks Z; Sandhoff K; Kolesnick R; Schuchman EH
Genomics; 2002 Feb; 79(2):218-24. PubMed ID: 11829492
[TBL] [Abstract][Full Text] [Related]
20. Retrovirus-mediated correction of the metabolic defect in cultured Farber disease cells.
Medin JA; Takenaka T; Carpentier S; Garcia V; Basile JP; Segui B; Andrieu-Abadie N; Auge N; Salvayre R; Levade T
Hum Gene Ther; 1999 May; 10(8):1321-9. PubMed ID: 10365663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
